- Home
- CHNR vs ABVC Comparison
CHNR vs ABVC Comparison
Compare CHNR & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- ABVC
- Stock Information
- Founded
- CHNR N/A
- ABVC 2015
- Country
- CHNR Hong Kong
- ABVC United States
- Employees
- CHNR N/A
- ABVC N/A
- Industry
- CHNR Precious Metals
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- ABVC Health Care
- Exchange
- CHNR Nasdaq
- ABVC Nasdaq
- Market Cap
- CHNR 6.0M
- ABVC 6.5M
- IPO Year
- CHNR 1995
- ABVC N/A
- Fundamental
- Price
- CHNR $0.56
- ABVC $0.48
- Analyst Decision
- CHNR
- ABVC
- Analyst Count
- CHNR 0
- ABVC 0
- Target Price
- CHNR N/A
- ABVC N/A
- AVG Volume (30 Days)
- CHNR 51.4K
- ABVC 361.4K
- Earning Date
- CHNR 01-01-0001
- ABVC 11-14-2024
- Dividend Yield
- CHNR N/A
- ABVC N/A
- EPS Growth
- CHNR N/A
- ABVC N/A
- EPS
- CHNR N/A
- ABVC N/A
- Revenue
- CHNR N/A
- ABVC $509,788.00
- Revenue This Year
- CHNR N/A
- ABVC N/A
- Revenue Next Year
- CHNR N/A
- ABVC N/A
- P/E Ratio
- CHNR N/A
- ABVC N/A
- Revenue Growth
- CHNR N/A
- ABVC N/A
- 52 Week Low
- CHNR $0.51
- ABVC $0.41
- 52 Week High
- CHNR $8.85
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- CHNR 41.98
- ABVC 36.66
- Support Level
- CHNR $0.54
- ABVC $0.47
- Resistance Level
- CHNR $0.77
- ABVC $0.52
- Average True Range (ATR)
- CHNR 0.04
- ABVC 0.04
- MACD
- CHNR -0.00
- ABVC -0.00
- Stochastic Oscillator
- CHNR 23.08
- ABVC 25.56
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.